MD4341B1 - Сироп для лечения предраковых состояний желудка - Google Patents
Сироп для лечения предраковых состояний желудка Download PDFInfo
- Publication number
- MD4341B1 MD4341B1 MD20130088A MD20130088A MD4341B1 MD 4341 B1 MD4341 B1 MD 4341B1 MD 20130088 A MD20130088 A MD 20130088A MD 20130088 A MD20130088 A MD 20130088A MD 4341 B1 MD4341 B1 MD 4341B1
- Authority
- MD
- Moldova
- Prior art keywords
- vitamin
- syrup
- treatment
- precancerous conditions
- gastric precancerous
- Prior art date
Links
- 235000020357 syrup Nutrition 0.000 title abstract 3
- 239000006188 syrup Substances 0.000 title abstract 3
- 208000006994 Precancerous Conditions Diseases 0.000 title abstract 2
- 230000002496 gastric effect Effects 0.000 title abstract 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 abstract 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 abstract 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 abstract 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 abstract 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 abstract 1
- PMYDPQQPEAYXKD-UHFFFAOYSA-N 3-hydroxy-n-naphthalen-2-ylnaphthalene-2-carboxamide Chemical compound C1=CC=CC2=CC(NC(=O)C3=CC4=CC=CC=C4C=C3O)=CC=C21 PMYDPQQPEAYXKD-UHFFFAOYSA-N 0.000 abstract 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 abstract 1
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 abstract 1
- 239000005751 Copper oxide Substances 0.000 abstract 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 abstract 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 abstract 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 abstract 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 abstract 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 abstract 1
- 229930003451 Vitamin B1 Natural products 0.000 abstract 1
- 229930003779 Vitamin B12 Natural products 0.000 abstract 1
- 229930003471 Vitamin B2 Natural products 0.000 abstract 1
- 229930003268 Vitamin C Natural products 0.000 abstract 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 abstract 1
- 229930003427 Vitamin E Natural products 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 abstract 1
- 235000020958 biotin Nutrition 0.000 abstract 1
- 239000011616 biotin Substances 0.000 abstract 1
- 229960002685 biotin Drugs 0.000 abstract 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 abstract 1
- 229910000431 copper oxide Inorganic materials 0.000 abstract 1
- 229960004643 cupric oxide Drugs 0.000 abstract 1
- 229960002061 ergocalciferol Drugs 0.000 abstract 1
- 229960000304 folic acid Drugs 0.000 abstract 1
- 235000019152 folic acid Nutrition 0.000 abstract 1
- 239000011724 folic acid Substances 0.000 abstract 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
- 239000000395 magnesium oxide Substances 0.000 abstract 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 abstract 1
- 229960000869 magnesium oxide Drugs 0.000 abstract 1
- 235000012245 magnesium oxide Nutrition 0.000 abstract 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 abstract 1
- 239000002105 nanoparticle Substances 0.000 abstract 1
- 229960003512 nicotinic acid Drugs 0.000 abstract 1
- 235000001968 nicotinic acid Nutrition 0.000 abstract 1
- 239000011664 nicotinic acid Substances 0.000 abstract 1
- 229940055726 pantothenic acid Drugs 0.000 abstract 1
- 235000019161 pantothenic acid Nutrition 0.000 abstract 1
- 239000011713 pantothenic acid Substances 0.000 abstract 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract 1
- 229960002477 riboflavin Drugs 0.000 abstract 1
- 229910052709 silver Inorganic materials 0.000 abstract 1
- 239000004332 silver Substances 0.000 abstract 1
- 235000020374 simple syrup Nutrition 0.000 abstract 1
- 239000011655 sodium selenate Substances 0.000 abstract 1
- 229960001881 sodium selenate Drugs 0.000 abstract 1
- 235000018716 sodium selenate Nutrition 0.000 abstract 1
- 229960003495 thiamine Drugs 0.000 abstract 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 abstract 1
- 235000019155 vitamin A Nutrition 0.000 abstract 1
- 239000011719 vitamin A Substances 0.000 abstract 1
- 235000010374 vitamin B1 Nutrition 0.000 abstract 1
- 239000011691 vitamin B1 Substances 0.000 abstract 1
- 235000019163 vitamin B12 Nutrition 0.000 abstract 1
- 239000011715 vitamin B12 Substances 0.000 abstract 1
- 235000019164 vitamin B2 Nutrition 0.000 abstract 1
- 239000011716 vitamin B2 Substances 0.000 abstract 1
- 235000019158 vitamin B6 Nutrition 0.000 abstract 1
- 239000011726 vitamin B6 Substances 0.000 abstract 1
- 235000019154 vitamin C Nutrition 0.000 abstract 1
- 239000011718 vitamin C Substances 0.000 abstract 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 abstract 1
- 235000001892 vitamin D2 Nutrition 0.000 abstract 1
- 239000011653 vitamin D2 Substances 0.000 abstract 1
- 235000019165 vitamin E Nutrition 0.000 abstract 1
- 239000011709 vitamin E Substances 0.000 abstract 1
- 229940046009 vitamin E Drugs 0.000 abstract 1
- 229940045997 vitamin a Drugs 0.000 abstract 1
- 229940011671 vitamin b6 Drugs 0.000 abstract 1
- 239000011787 zinc oxide Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Изобретение относится к гастроэнтерологии, в частности к биологически активным веществам в виде сиропов, которые могут быть использованы для лечения предраковых состояний желудка.Согласно изобретению, заявленный сироп состоит из: витамин А, витамин D2, витамин Е, витамин С, витамин B1, витамин B2, ниацин, витамин B6, витамин B12, биотин, фолиевая кислота, пантотеновая кислота, оксид магния, оксид меди, селенат натрия, наночастицы оксида цинка и серебра, взятые в соотношении 9:1, и сахарный сироп, при следующем количественном соотношении компонентов, на 100 мл:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20130088A MD4341C1 (ru) | 2013-11-21 | 2013-11-21 | Сироп для лечения предраковых состояний желудка |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20130088A MD4341C1 (ru) | 2013-11-21 | 2013-11-21 | Сироп для лечения предраковых состояний желудка |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD4341B1 true MD4341B1 (ru) | 2015-04-30 |
| MD4341C1 MD4341C1 (ru) | 2015-11-30 |
Family
ID=53002924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20130088A MD4341C1 (ru) | 2013-11-21 | 2013-11-21 | Сироп для лечения предраковых состояний желудка |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD4341C1 (ru) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991002535A1 (en) * | 1989-08-11 | 1991-03-07 | Basil, Inc. | Cancer prevention composition and method |
| DE4032163C2 (de) * | 1990-10-10 | 1995-03-30 | Gradinger F Hermes Pharma | S-Retinoyl-L-aminomercapto-Verbindungen und Zwischenprodukte, Verfahren zu ihrer Herstellung und ihre Verwendung |
| DE4032187C2 (de) * | 1990-10-10 | 1995-03-30 | Gradinger F Hermes Pharma | N-Retinoyl-L-aminomercapto-Verbindungen und Zwischenprodukte, Verfahren zu ihrer Herstellung und ihre Verwendung |
| RU2034560C1 (ru) * | 1993-05-18 | 1995-05-10 | Товарищество с ограниченной ответственностью "Фитолон" | Средство для профилактики рака "кламин" |
| CN1093402C (zh) * | 1998-08-11 | 2002-10-30 | 苏乐群 | 一种治疗胃炎的片剂 |
| DE10119680A1 (de) * | 2001-04-20 | 2002-11-14 | Boehringer Ingelheim Pharma | Verwendung von Radikalfänger-Verbindungen zur Behandlung und Verhinderung von no-abhängigen Störungen der Mikrozirkulation |
| RU2205656C1 (ru) * | 2002-06-27 | 2003-06-10 | Общество с ограниченной ответственностью Фирма "ЭЙКОСЪ" | Биологически активная добавка "антиязвенные" для профилактики и поддерживающей терапии заболеваний желудочно-кишечного тракта |
| CN100349578C (zh) * | 2005-04-29 | 2007-11-21 | 朱舜时 | 治疗萎缩性胃炎的药物组合物 |
| CN1927311A (zh) * | 2006-09-19 | 2007-03-14 | 陈楚挺 | 治疗慢性萎缩性胃炎癌前病变的药物与其成品胶囊 |
| MD3972C2 (ru) * | 2009-03-11 | 2010-07-31 | Ион МЕРЕУЦЭ | Средство и метод лечения предраковых состояний |
| RU2473357C2 (ru) * | 2011-02-24 | 2013-01-27 | Общество с ограниченной ответственностью "ДИНАМИК ДЕВЕЛОПМЕНТ ЛАБОРАТОРИЗ" | Жидкая композиция, повышающая работоспособность и обладающая адаптогенным, ранозаживляющим, противовоспалительным действием |
| CN103082299B (zh) * | 2012-12-26 | 2014-07-30 | 东莞市照燕生物科技有限公司 | 一种清肠排毒的营养保健品 |
| CN103230431A (zh) * | 2013-04-27 | 2013-08-07 | 洪士炀 | 治疗胃病的药物及用途 |
-
2013
- 2013-11-21 MD MDA20130088A patent/MD4341C1/ru not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MD4341C1 (ru) | 2015-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR081551A1 (es) | Composiciones y bebidas que comprenden nutrientes, vitaminas, azucares, cisteina y/o productos de azucar-cisteina | |
| HK1244710A1 (zh) | 微胶囊化大麻素组合物 | |
| MX375509B (es) | Empleo de una composición que comprende microorganismos para aumentar la producción intestinal de ácido butírico, ácido fólico o niacina y/o disminuir la producción intestinal de ácido succínico. | |
| EP4245765A3 (en) | Treatment of metabolic disorders in equine animals | |
| PH12014500075A1 (en) | Pharmaceutical composition, methods for treating and uses thereof | |
| BR112012017868A2 (pt) | "composição beseadas em gel e métodos de fabricação das mesmas" | |
| GB2502032A (en) | Vitamin D composition | |
| AR098653A1 (es) | Composición útil para promover la fertilidad femenina, composición de combinación | |
| MX2018003975A (es) | Combinacion de glicosaminoglicanos y un agente antacido y sus composiciones. | |
| MX2011012297A (es) | Mejoramiento de la salud gastrointestinal, la inmunidad y el rendimiento mediante intervención dietética. | |
| PH12013500761A1 (en) | Cysteine and food intake | |
| HK1253577A1 (zh) | 含钯的锡/铜合金、用於其制备的方法及其用途 | |
| AR100028A1 (es) | Composiciones nutricionales que contienen ácido estearidónico | |
| MD4341B1 (ru) | Сироп для лечения предраковых состояний желудка | |
| WO2011019867A3 (en) | Dietary supplements and methods for treating pain and inflammation | |
| GB201207939D0 (en) | Nutraceutical composition that comprises extract of shilajit, folic acid, vitamin b12 and vitamin b6 and the use thereof for preventing and/or treating neurod | |
| SG10201909401UA (en) | Oral delivery product | |
| MX2018013148A (es) | Suplementos nutricionales. | |
| PH12015501803A1 (en) | Oral electrolyte solution containing lactoferrin and uses thereof | |
| PH12015502019A1 (en) | Sequestrants of advanced glycation end product (age) precursors | |
| LI et al. | HPLC determination of nicotinamide, vitamin B1, vitamin B2 and vitamin B6 in Baweigaixin tablets | |
| MX2013012004A (es) | Proceso para la obtencion de una harina con reducida astringencia, alto contenido de fibra, vitamina a y vitamina c del pseudofruto de marañon (anacardium occidentale l.), usos y aplicaciones. | |
| UA86343U (ru) | Состав мармелада с оздоровительными свойствами "свежесть" | |
| PH22014000502U3 (en) | Composition of guyabano (annona muricata) calamansi (citrofortunella microcarpa) juice drink | |
| UA90307U (ru) | Способ лечения пищевых отравлений с помощью яблочного уксуса |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG4A | Patent for invention issued | ||
| KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
| MM4A | Patent for invention definitely lapsed due to non-payment of fees |